Naloxonazine|CAS 82824-01-9|DC Chemicals

Cas No.:	82824-01-9
Chemical Name:	Naloxonazine
SMILES:	O[C@@]1(CC/2)[C@@]([C@](O3)([H])C2=N\N=C(CC4)\[C@@](OC5=C6O)([H])[C@]7(CCN8CC=C)C5=C(C=C6)C[C@]8([H])[C@@]74O)(CC9)C(C3=C%10O)=C(C=C%10)C[C@@]1([H])N9CC=C
Formula:	C₃₈H₄₂N₄O₆
M.Wt:	650.76
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC72634	(Rac)-SNC80	(Rac)-SNC80 is a racemate of SNC80. SNC80 (NIH 10815) is a potent, highly selective and non-peptide δ-opioid receptor agonist with a Ki of 1.78 nM and an IC50 of 2.73 nM. SNC80 shows antinociceptive, antihyperalgesic and antidepressant‐like effects. SNC80 has the potential for multiple headache disorders treatment.
DC46693	DAMGO	DAMGO (DAGO) is a potent and selective μ opioid receptor agonist with ki of 17 nM.
DC44976	LY2940094 tartrate	LY2940094 (BTRX-246040) tartrate is a potent, brain penetrant, selective and orally available N/OFQ peptide (NOP) receptor antagonist with high affinity (Ki=0.105 nM) and antagonist potency (Kb=0.166 nM). LY2940094 tartrate reduces Ethanol self-administration and Ethanol seeking in animal models.
DC41767	Nociceptin(1-7) TFA	Nociceptin (1-7) TFA is the N-terminal bioactive fragment of nociceptin. Nociceptin (1-7) TFA is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) TFA combines with nociceptin reduces hyperalgesia in vivo.
DC41766	Nociceptin(1-7)	Nociceptin (1-7) is the N-terminal bioactive fragment of nociceptin. Nociceptin (1-7) is a potent ORL1 (NOP) receptor agonist with antinociceptive activity. Nociceptin (1-7) combines with nociceptin reduces hyperalgesia in vivo.
DC40982	Loperamide phenyl	Loperamide phenyl is an impurity of Loperamide. Loperamide is an opioid receptor agonist.
DC28780	LY2444296	LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects.
DC10290	PZM21	PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM.
DC9527	Methylnaltrexone (Bromide)	Methylnaltrexone Bromide is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation.
DC9526	Meptazinol (hydrochloride)	Meptazinol Hcl(WY-22811 Hcl) is a unique centrally active opioid analgesic.